Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on July 24, 2008, to report its financial results for the second quarter of 2008. The filing primarily serves to provide investors with access to the official press release detailing these results and associated supplemental financial information. While the 8-K itself does not contain the detailed financial figures, it directs investors to these furnished exhibits for a comprehensive understanding of the company's performance during the reported quarter. Investors interested in BMY's performance should refer to the provided press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) for detailed insights into revenue, earnings, and any significant financial developments. This report acts as a formal notification mechanism, ensuring timely dissemination of crucial financial data as per SEC regulations.
Key Highlights
- 1Bristol-Myers Squibb (BMY) reported its second-quarter 2008 financial results on July 24, 2008.
- 2The 8-K filing's primary purpose is to furnish the official earnings press release.
- 3Investors can access the Q2 2008 financial results through the press release (Exhibit 99.1).
- 4Additional supplemental financial information is available on BMY's website and also furnished as an exhibit (Exhibit 99.2).
- 5The filing confirms the company's adherence to reporting its financial performance in a timely manner.
- 6No new material events or specific financial figures are detailed directly within the 8-K form itself, as it refers to external documents.